Fortitude Mining Holdings, Inc. to Acquire HeartSciences Inc. in All-Stock Transaction
Acquiring Company
Fortitude Mining Holdings
Acquired Company
HeartSciences
New YorkSouthlakeBlockchainCryptocurrencyMiningMining TechnologyBiotechnologyHealthcareMedical Equipment ManufacturingDescription
On June 23, 2026, Fortitude Mining Holdings, Inc. and HeartSciences Inc. announced a definitive merger agreement for an all-stock transaction. The merger aims to combine the strengths of both companies in their respective industries. This transaction reflects Fortitude's commitment to diversification and growth by entering the healthcare sector. The companies anticipate completing the merger after meeting regulatory requirements.
Don't miss Fortitude Mining Holdings's next move
Get an email the moment Fortitude Mining Holdings makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired HeartSciences?
HeartSciences was acquired by Fortitude Mining Holdings, based in New York. The deal was reported on September 15, 2026. Fortitude is a leading Zcash mining platform, wholly-owned by Digital Currency Group. It applies a venture mining approach across high-growth digital assets with a primary focus on Zcash. Fortitude Mining Holdings is privately held and operates in Blockchain.
When did Fortitude Mining Holdings acquire HeartSciences?
Fortitude Mining Holdings's acquisition of HeartSciences was reported on September 15, 2026. On June 23, 2026, Fortitude Mining Holdings, Inc. and HeartSciences Inc. announced a definitive merger agreement for an all-stock transaction. The merger aims to combine the strengths of both companies in their respective industries. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does HeartSciences do?
HeartSciences Inc. is a medical technology company focused on developing innovative solutions for cardiac diagnostics. The company aims to improve the detection and management of heart diseases through advanced technologies. It is publicly traded (HSCS), operating in Biotechnology, and is based in Southlake.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.